Skip to main content
Journal cover image

Effect of mode of intraoperative support on primary graft dysfunction after lung transplant.

Publication ,  Journal Article
Loor, G; Huddleston, S; Hartwig, M; Bottiger, B; Daoud, D; Wei, Q; Zhang, Q; Ius, F; Warnecke, G; Villavicencio, MA; Tirabassi, B; Machuca, TN ...
Published in: J Thorac Cardiovasc Surg
November 2022

OBJECTIVE: To clarify the relationship between the use of extracorporeal life support during lung transplantation and severe primary graft dysfunction (PGD), we developed and analyzed a novel multicenter international registry. METHODS: The Extracorporeal Life Support in Lung Transplantation Registry includes double-lung transplants performed at 8 high-volume centers (>40/year). Multiorgan transplants were excluded. We defined severe PGD as grade 3 PGD (PGD3) observed 48 or 72 hours after reperfusion. Modes of support were no extracorporeal life support (off-pump), extracorporeal membrane oxygenation (ECMO), and cardiopulmonary bypass (CPB). To assess the association between mode of support and PGD3, we adjusted for demographic and intraoperative factors with a stepwise, mixed selection, multivariable regression model, ending with 10 covariates in the final model. RESULTS: We analyzed 852 transplants performed between January 2016 and March 2020: 422 (50%) off-pump, 273 (32%) ECMO, and 157 (18%) CPB cases. PGD3 rates at time point 48-72 were 12.1% (51 out of 422) for off-pump, 28.9% for ECMO (79 out of 273), and 42.7% (67 out of 157) for CPB. The adjusted model resulted in the following risk profile for PGD3: CPB versus ECMO odds ratio, 1.89 (95% CI, 1.05-3.41; P = .033), CPB versus off-pump odds ratio, 4.24 (95% CI, 2.24-8.04; P < .001), and ECMO versus off-pump odds ratio, 2.24 (95% CI, 1.38-3.65; P = .001). CONCLUSIONS: Venoarterial ECMO is increasingly used at high-volume centers to support complex transplant recipients during double-lung transplantation. This practice is associated with more risk of PGD3 than off-pump transplantation but less risk than CPB. When extracorporeal life support is required during lung transplantation, ECMO may be the preferable approach when feasible.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Thorac Cardiovasc Surg

DOI

EISSN

1097-685X

Publication Date

November 2022

Volume

164

Issue

5

Start / End Page

1351 / 1361.e4

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Transplant Recipients
  • Retrospective Studies
  • Respiratory System
  • Primary Graft Dysfunction
  • Lung Transplantation
  • Humans
  • Extracorporeal Membrane Oxygenation
  • Cardiopulmonary Bypass
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Loor, G., Huddleston, S., Hartwig, M., Bottiger, B., Daoud, D., Wei, Q., … Chandrashekaran, S. (2022). Effect of mode of intraoperative support on primary graft dysfunction after lung transplant. J Thorac Cardiovasc Surg, 164(5), 1351-1361.e4. https://doi.org/10.1016/j.jtcvs.2021.10.076
Loor, Gabriel, Stephen Huddleston, Matthew Hartwig, Brandi Bottiger, Daoud Daoud, Qi Wei, Qianzi Zhang, et al. “Effect of mode of intraoperative support on primary graft dysfunction after lung transplant.J Thorac Cardiovasc Surg 164, no. 5 (November 2022): 1351-1361.e4. https://doi.org/10.1016/j.jtcvs.2021.10.076.
Loor G, Huddleston S, Hartwig M, Bottiger B, Daoud D, Wei Q, et al. Effect of mode of intraoperative support on primary graft dysfunction after lung transplant. J Thorac Cardiovasc Surg. 2022 Nov;164(5):1351-1361.e4.
Loor, Gabriel, et al. “Effect of mode of intraoperative support on primary graft dysfunction after lung transplant.J Thorac Cardiovasc Surg, vol. 164, no. 5, Nov. 2022, pp. 1351-1361.e4. Pubmed, doi:10.1016/j.jtcvs.2021.10.076.
Loor G, Huddleston S, Hartwig M, Bottiger B, Daoud D, Wei Q, Zhang Q, Ius F, Warnecke G, Villavicencio MA, Tirabassi B, Machuca TN, Van Raemdonck D, Frick AE, Neyrinck A, Toyoda Y, Kashem MA, Landeweer M, Chandrashekaran S. Effect of mode of intraoperative support on primary graft dysfunction after lung transplant. J Thorac Cardiovasc Surg. 2022 Nov;164(5):1351-1361.e4.
Journal cover image

Published In

J Thorac Cardiovasc Surg

DOI

EISSN

1097-685X

Publication Date

November 2022

Volume

164

Issue

5

Start / End Page

1351 / 1361.e4

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Transplant Recipients
  • Retrospective Studies
  • Respiratory System
  • Primary Graft Dysfunction
  • Lung Transplantation
  • Humans
  • Extracorporeal Membrane Oxygenation
  • Cardiopulmonary Bypass
  • 3202 Clinical sciences